ArticleCancers2022

Co-Targeting Luminal B Breast Cancer with S-Adenosylmethionine and Immune Checkpoint Inhibitor Reduces Primary Tumor Growth and Progression, and Metastasis to Lungs and Bone.

Ali Mehdi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.